OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Hyperuricemia starts at 360 micromoles (6mg/dL)
Thomas Bardin
Joint Bone Spine (2015) Vol. 82, Iss. 3, pp. 141-143
Closed Access | Times Cited: 77
Thomas Bardin
Joint Bone Spine (2015) Vol. 82, Iss. 3, pp. 141-143
Closed Access | Times Cited: 77
Showing 1-25 of 77 citing articles:
2016 updated EULAR evidence-based recommendations for the management of gout
Pascal Richette, Michael Doherty, Eliseo Pascual, et al.
Annals of the Rheumatic Diseases (2016) Vol. 76, Iss. 1, pp. 29-42
Open Access | Times Cited: 1401
Pascal Richette, Michael Doherty, Eliseo Pascual, et al.
Annals of the Rheumatic Diseases (2016) Vol. 76, Iss. 1, pp. 29-42
Open Access | Times Cited: 1401
2018 updated European League Against Rheumatism evidence-based recommendations for the diagnosis of gout
Pascal Richette, Michael Doherty, Eliseo Pascual, et al.
Annals of the Rheumatic Diseases (2019) Vol. 79, Iss. 1, pp. 31-38
Open Access | Times Cited: 335
Pascal Richette, Michael Doherty, Eliseo Pascual, et al.
Annals of the Rheumatic Diseases (2019) Vol. 79, Iss. 1, pp. 31-38
Open Access | Times Cited: 335
Gout: state of the art after a decade of developments
Tristan Pascart, Frédéric Lioté
Lara D. Veeken (2018)
Open Access | Times Cited: 159
Tristan Pascart, Frédéric Lioté
Lara D. Veeken (2018)
Open Access | Times Cited: 159
The NLRP3 inflammasome - interleukin 1 pathway as a therapeutic target in gout
Zoltán Szekanecz, Szilvia Szamosi, Gergő Kovács, et al.
Archives of Biochemistry and Biophysics (2019) Vol. 670, pp. 82-93
Closed Access | Times Cited: 77
Zoltán Szekanecz, Szilvia Szamosi, Gergő Kovács, et al.
Archives of Biochemistry and Biophysics (2019) Vol. 670, pp. 82-93
Closed Access | Times Cited: 77
Emerging Urate-Lowering Drugs and Pharmacologic Treatment Strategies for Gout: A Narrative Review
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 35
Robert Terkeltaub
Drugs (2023) Vol. 83, Iss. 16, pp. 1501-1521
Closed Access | Times Cited: 35
The gout epidemic in French Polynesia: a modelling study of data from the Ma’i u’u epidemiological survey
Tristan Pascart, Kaja A. Wasik, Cristian Preda, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 4, pp. e685-e696
Open Access | Times Cited: 14
Tristan Pascart, Kaja A. Wasik, Cristian Preda, et al.
The Lancet Global Health (2024) Vol. 12, Iss. 4, pp. e685-e696
Open Access | Times Cited: 14
Asymptomatic Hyperuricemia and the Kidney: Lessons from the URRAH Study
Cecilia Barnini, Elisa Russo, Giovanna Leoncini, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 11-11
Open Access | Times Cited: 1
Cecilia Barnini, Elisa Russo, Giovanna Leoncini, et al.
Metabolites (2025) Vol. 15, Iss. 1, pp. 11-11
Open Access | Times Cited: 1
Investigational drugs for hyperuricemia, an update on recent developments
Tristan Pascart, Pascal Richette
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 5, pp. 437-444
Closed Access | Times Cited: 72
Tristan Pascart, Pascal Richette
Expert Opinion on Investigational Drugs (2018) Vol. 27, Iss. 5, pp. 437-444
Closed Access | Times Cited: 72
2020 recommendations from the French Society of Rheumatology for the management of gout: Urate-lowering therapy
Tristan Pascart, Augustin Latourte, René‐Marc Flipo, et al.
Joint Bone Spine (2020) Vol. 87, Iss. 5, pp. 395-404
Open Access | Times Cited: 68
Tristan Pascart, Augustin Latourte, René‐Marc Flipo, et al.
Joint Bone Spine (2020) Vol. 87, Iss. 5, pp. 395-404
Open Access | Times Cited: 68
How should we manage asymptomatic hyperuricemia?
Gérard Chalès
Joint Bone Spine (2018) Vol. 86, Iss. 4, pp. 437-443
Closed Access | Times Cited: 66
Gérard Chalès
Joint Bone Spine (2018) Vol. 86, Iss. 4, pp. 437-443
Closed Access | Times Cited: 66
Trained immunity and inflammation in rheumatic diseases
Medeea Badii, Orsolya I. Gaal, Radu A. Popp, et al.
Joint Bone Spine (2022) Vol. 89, Iss. 4, pp. 105364-105364
Open Access | Times Cited: 32
Medeea Badii, Orsolya I. Gaal, Radu A. Popp, et al.
Joint Bone Spine (2022) Vol. 89, Iss. 4, pp. 105364-105364
Open Access | Times Cited: 32
Effect of fenofibrate on uric acid and gout in type 2 diabetes: a post-hoc analysis of the randomised, controlled FIELD study
Boris Waldman, Jean-Claude Ansquer, David Sullivan, et al.
The Lancet Diabetes & Endocrinology (2018) Vol. 6, Iss. 4, pp. 310-318
Closed Access | Times Cited: 56
Boris Waldman, Jean-Claude Ansquer, David Sullivan, et al.
The Lancet Diabetes & Endocrinology (2018) Vol. 6, Iss. 4, pp. 310-318
Closed Access | Times Cited: 56
Injection Techniques for Common Chronic Pain Conditions of the Foot: A Comprehensive Review
Ivan Urits, Daniel Smoots, Henry Franscioni, et al.
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 145-160
Open Access | Times Cited: 44
Ivan Urits, Daniel Smoots, Henry Franscioni, et al.
Pain and Therapy (2020) Vol. 9, Iss. 1, pp. 145-160
Open Access | Times Cited: 44
Elevated triglyceride to high-density lipoprotein cholesterol (TG/HDL-C) ratio increased risk of hyperuricemia: a 4-year cohort study in China
Xinyao Liu, Qiaoyu Wu, Zhiheng Chen, et al.
Endocrine (2020) Vol. 68, Iss. 1, pp. 71-80
Closed Access | Times Cited: 42
Xinyao Liu, Qiaoyu Wu, Zhiheng Chen, et al.
Endocrine (2020) Vol. 68, Iss. 1, pp. 71-80
Closed Access | Times Cited: 42
Hyperuricemia, Gout, and the Brain—an Update
Augustin Latourte, Julien Dumurgier, Claire Paquet, et al.
Current Rheumatology Reports (2021) Vol. 23, Iss. 12
Closed Access | Times Cited: 35
Augustin Latourte, Julien Dumurgier, Claire Paquet, et al.
Current Rheumatology Reports (2021) Vol. 23, Iss. 12
Closed Access | Times Cited: 35
Early-onset gout
Tristan Pascart, Vincent Ducoulombier, Charlotte Jauffret
Joint Bone Spine (2024) Vol. 91, Iss. 5, pp. 105704-105704
Open Access | Times Cited: 5
Tristan Pascart, Vincent Ducoulombier, Charlotte Jauffret
Joint Bone Spine (2024) Vol. 91, Iss. 5, pp. 105704-105704
Open Access | Times Cited: 5
Current and future therapies for gout
Tristan Pascart, Pascal Richette
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 12, pp. 1201-1211
Closed Access | Times Cited: 47
Tristan Pascart, Pascal Richette
Expert Opinion on Pharmacotherapy (2017) Vol. 18, Iss. 12, pp. 1201-1211
Closed Access | Times Cited: 47
Exploration into Uric and Cardiovascular Disease: Uric Acid Right for heArt Health (URRAH) Project, A Study Protocol for a Retrospective Observational Study
Giovambattista Desideri, Agostino Virdis, Edoardo Casiglia, et al.
High Blood Pressure & Cardiovascular Prevention (2018) Vol. 25, Iss. 2, pp. 197-202
Closed Access | Times Cited: 41
Giovambattista Desideri, Agostino Virdis, Edoardo Casiglia, et al.
High Blood Pressure & Cardiovascular Prevention (2018) Vol. 25, Iss. 2, pp. 197-202
Closed Access | Times Cited: 41
Psoriatic arthritis with hyperuricemia: more peripheral, destructive, and challenging to treat
L. Widawski, Thibaut Fabacher, Lionel Spielmann, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 5, pp. 1421-1429
Open Access | Times Cited: 19
L. Widawski, Thibaut Fabacher, Lionel Spielmann, et al.
Clinical Rheumatology (2022) Vol. 41, Iss. 5, pp. 1421-1429
Open Access | Times Cited: 19
Association between dietary folate and hyperuricemia based on inflammation and cardiovascular disease status
Eugene Chang, Yoonjin Shin
Nutrition Metabolism and Cardiovascular Diseases (2025), pp. 104108-104108
Closed Access
Eugene Chang, Yoonjin Shin
Nutrition Metabolism and Cardiovascular Diseases (2025), pp. 104108-104108
Closed Access
Persistent clinical inertia in gout in 2014: An observational French longitudinal patient database study
Milka Maravic, Natalia Correa Hincapié, Simon Pilet, et al.
Joint Bone Spine (2017) Vol. 85, Iss. 3, pp. 311-315
Closed Access | Times Cited: 33
Milka Maravic, Natalia Correa Hincapié, Simon Pilet, et al.
Joint Bone Spine (2017) Vol. 85, Iss. 3, pp. 311-315
Closed Access | Times Cited: 33
Metabolic syndrome, serum uric acid and renal risk in patients with T2D
Francesca Viazzi, Pamela Piscitelli, Carlo Giorda, et al.
PLoS ONE (2017) Vol. 12, Iss. 4, pp. e0176058-e0176058
Open Access | Times Cited: 32
Francesca Viazzi, Pamela Piscitelli, Carlo Giorda, et al.
PLoS ONE (2017) Vol. 12, Iss. 4, pp. e0176058-e0176058
Open Access | Times Cited: 32
High-level uric acid in asymptomatic hyperuricemia could be an isolated risk factor of cardio-cerebrovascular diseases: A prospective cohort study
Zhiyuan Cheng, Tongzhang Zheng, Desheng Zhang, et al.
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 31, Iss. 12, pp. 3415-3425
Open Access | Times Cited: 20
Zhiyuan Cheng, Tongzhang Zheng, Desheng Zhang, et al.
Nutrition Metabolism and Cardiovascular Diseases (2021) Vol. 31, Iss. 12, pp. 3415-3425
Open Access | Times Cited: 20
The URRAH study
Rita Del Pinto, Francesca Viazzi, Roberto Pontremoli, et al.
Panminerva Medica (2021) Vol. 63, Iss. 4
Closed Access | Times Cited: 20
Rita Del Pinto, Francesca Viazzi, Roberto Pontremoli, et al.
Panminerva Medica (2021) Vol. 63, Iss. 4
Closed Access | Times Cited: 20
Hyperuricaemia: prevalence and association with mortality in an elderly Finnish population
Janis Timsans, Jenni Emilia Kauppi, Anne M Kerola, et al.
BMJ Open (2023) Vol. 13, Iss. 5, pp. e072110-e072110
Open Access | Times Cited: 8
Janis Timsans, Jenni Emilia Kauppi, Anne M Kerola, et al.
BMJ Open (2023) Vol. 13, Iss. 5, pp. e072110-e072110
Open Access | Times Cited: 8
